Mocetinostat 200 mg | 99.37%
TargetMol
Mocetinostat is an orally available HDAC inhibitor with most potency for HDAC1 (IC50: 0.15 μM), 2- to 10- fold selectivity against HDAC2/3/11.
More Information Supplier PageMocetinostat
Search Results
Gadodiamide 50 mg | 99.74%
TargetMol
Gadodiamide is an MRI contrast agent, used in MR imaging procedures to assist in the visualization of blood vessels.
More Information Supplier PageGadodiamide
Thiazovivin 10 mg | Purity Not Available
TargetMol
Thiazovivin, a ROCK inhibitor (IC50: 0.5 μM), increases the survival rate of hESC.
More Information Supplier PageThiazovivin
SGC-GAK-1 25 mg | Purity Not Available
TargetMol
SGC-GAK-1 is a selective cyclin G-associated kinase (GAK) inhibitor (Ki: 3.1 nM).
More Information Supplier PageSGC-GAK-1
SGC-GAK-1 10 mg | Purity Not Available
TargetMol
SGC-GAK-1 is a selective cyclin G-associated kinase (GAK) inhibitor (Ki: 3.1 nM).
More Information Supplier PageSGC-GAK-1
SGC-GAK-1 5 mg | Purity Not Available
TargetMol
SGC-GAK-1 is a selective cyclin G-associated kinase (GAK) inhibitor (Ki: 3.1 nM).
More Information Supplier PageSGC-GAK-1
SGC-GAK-1 1 mg | Purity Not Available
TargetMol
SGC-GAK-1 is a selective cyclin G-associated kinase (GAK) inhibitor (Ki: 3.1 nM).
More Information Supplier PageSGC-GAK-1
Gadodiamide 100 mg | 99.74%
TargetMol
Gadodiamide is an MRI contrast agent, used in MR imaging procedures to assist in the visualization of blood vessels.
More Information Supplier PageGadodiamide
ABT530 100 mg | Purity Not Available
TargetMol
ABT-530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
More Information Supplier PageABT530
ABT530 50 mg | Purity Not Available
TargetMol
ABT-530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
More Information Supplier PageABT530
